These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 782685)

  • 1. Combination chemotherapy of the malignant lymphomas: a controlled clinical trial.
    Lenhard RE; Prentice RL; Owens AH; Bakemeier R; Horton JH; Shnider BI; Stolbach L; Berard CW; Carbone PP
    Cancer; 1976 Sep; 38(3):1052-9. PubMed ID: 782685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens.
    Cabanillas F; Rodriguez V; Freireich EJ
    Med Pediatr Oncol; 1978; 4(4):321-31. PubMed ID: 364284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of non-Hodgkin lymphoma.
    Forcier RJ; McIntyre OR; Nissen NI; Pajak TF; Glidewell O; Holland JF
    Med Pediatr Oncol; 1978; 4(4):351-62. PubMed ID: 364285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse histiocytic lymphoma. The need for aggressive restaging.
    Weinerman BH; Levitt M; Babick T
    JAMA; 1977 May; 237(22):2403-4. PubMed ID: 323527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of lymphomas other than Hodgkin's disease.
    Stein RS; Moran EM; Desser RK; Miller JB; Golomb HM; Ultmann JE
    Ann Intern Med; 1974 Nov; 81(5):601-8. PubMed ID: 4608355
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
    Luce JK; Gamble JF; Wilson HE; Monto RW; Isaacs BL; Palmer RL; Coltman CA; Hewlett JS; Gehan EA; Frei E
    Cancer; 1971 Aug; 28(2):306-17. PubMed ID: 4935774
    [No Abstract]   [Full Text] [Related]  

  • 8. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up study.
    Hayes DM; Pajak TF; Rege V; Falkson G; Spurr CL; Silver RT; Nissen NI; Harley JB; Cuttner J; Glidewell O; Holland JF
    Med Pediatr Oncol; 1979; 6(1):23-38. PubMed ID: 375053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic chemotherapy in lymphoma.
    Mukherji B; Oettgen HF; Yagoda A; Krakoff IH
    Cancer; 1971 Oct; 28(4):886-93. PubMed ID: 4939250
    [No Abstract]   [Full Text] [Related]  

  • 11. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
    Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
    Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G; Monfardini S; Villa E
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).
    Herold M; Schulze A; Niederwieser D; Franke A; Fricke HJ; Richter P; Freund M; Ismer B; Dachselt K; Boewer C; Schirmer V; Weniger J; Pasold R; Winkelmann C; Klinkenstein C; Schulze M; Arzberger H; Bremer K; Hahnfeld S; Schwarzer A; Müller C; Müller C;
    J Cancer Res Clin Oncol; 2006 Feb; 132(2):105-12. PubMed ID: 16088404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
    Elias L; Portlock CS; Rosenberg SA
    Cancer; 1978 Oct; 42(4):1705-10. PubMed ID: 361209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy.
    Lenhard RE; Ezdinli EZ; Costello W; Bennett JM; Horton J; Amorisi EL; Stolbach L; Wolter J
    Cancer; 1978 Jul; 42(1):41-52. PubMed ID: 352507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.